CN1166618C - 新型选择性视黄醛激动剂 - Google Patents

新型选择性视黄醛激动剂 Download PDF

Info

Publication number
CN1166618C
CN1166618C CNB008112568A CN00811256A CN1166618C CN 1166618 C CN1166618 C CN 1166618C CN B008112568 A CNB008112568 A CN B008112568A CN 00811256 A CN00811256 A CN 00811256A CN 1166618 C CN1166618 C CN 1166618C
Authority
CN
China
Prior art keywords
alkyl
hexahydro
tetramethyl
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB008112568A
Other languages
English (en)
Chinese (zh)
Other versions
CN1368946A (zh
Inventor
���ء����߸�
保拉·南妮特·贝略尼
米切尔·克劳斯
��١���Ƥ˹��
琼－马蕾·拉皮埃尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Setters
Original Assignee
Setters
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Setters filed Critical Setters
Publication of CN1368946A publication Critical patent/CN1368946A/zh
Application granted granted Critical
Publication of CN1166618C publication Critical patent/CN1166618C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/57—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C233/63—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/28—Unsaturated compounds polycyclic
    • C07C61/29—Unsaturated compounds polycyclic having a carboxyl group bound to a condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
    • C07C63/66—Polycyclic acids with unsaturation outside the aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C69/753—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring of polycyclic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNB008112568A 1999-08-02 2000-07-25 新型选择性视黄醛激动剂 Expired - Fee Related CN1166618C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99115223.2 1999-08-02
EP99115223 1999-08-02

Publications (2)

Publication Number Publication Date
CN1368946A CN1368946A (zh) 2002-09-11
CN1166618C true CN1166618C (zh) 2004-09-15

Family

ID=8238709

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB008112568A Expired - Fee Related CN1166618C (zh) 1999-08-02 2000-07-25 新型选择性视黄醛激动剂

Country Status (18)

Country Link
US (3) US6528677B1 (https=)
EP (1) EP1206436B1 (https=)
JP (1) JP3961827B2 (https=)
KR (1) KR100466730B1 (https=)
CN (1) CN1166618C (https=)
AR (1) AR024998A1 (https=)
AT (1) ATE279386T1 (https=)
AU (1) AU772551B2 (https=)
BR (1) BR0012951A (https=)
CA (1) CA2386793C (https=)
DE (1) DE60014928T2 (https=)
DK (1) DK1206436T3 (https=)
ES (1) ES2228587T3 (https=)
MX (1) MXPA02000828A (https=)
PT (1) PT1206436E (https=)
TR (1) TR200200263T2 (https=)
WO (1) WO2001009076A2 (https=)
ZA (1) ZA200200516B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO2178B1 (en) * 1999-10-19 2003-04-23 اف . هوفمان لاروش ايه جي Treatment of emphysema using rar selective retinoid antagonists
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US7914437B2 (en) * 2005-02-04 2011-03-29 Ams Research Corporation Transobturator methods for installing sling to treat incontinence, and related devices
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
EP3050566B1 (en) 2007-09-10 2018-11-28 Boston Biomedical, Inc. A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
EP2547205B1 (en) 2010-03-19 2024-03-20 1Globe Biomedical Co., Ltd. Novel methods for targeting cancer stem cells
US8772273B2 (en) * 2011-10-04 2014-07-08 Quretino Therapeutics, Inc. Formulations and uses of retinoic acid receptor selective agonists
CA2856703A1 (en) * 2011-10-19 2013-04-25 Bikam Pharmaceuticals, Inc. Opsin-binding ligands, compositions and methods of use
EP2983790A2 (en) 2013-04-09 2016-02-17 Boston Biomedical, Inc. Methods for treating cancer
EP3102576B8 (en) 2014-02-03 2019-06-19 Vitae Pharmaceuticals, LLC Dihydropyrrolopyridine inhibitors of ror-gamma
PT3207043T (pt) 2014-10-14 2019-03-25 Vitae Pharmaceuticals Llc Inibidores de di-hidropirrolopiridina de ror-gama
US9663515B2 (en) 2014-11-05 2017-05-30 Vitae Pharmaceuticals, Inc. Dihydropyrrolopyridine inhibitors of ROR-gamma
WO2017024018A1 (en) 2015-08-05 2017-02-09 Vitae Pharmaceuticals, Inc. Modulators of ror-gamma
US11008340B2 (en) 2015-11-20 2021-05-18 Vitae Pharmaceuticals, Llc Modulators of ROR-gamma
TW202220968A (zh) 2016-01-29 2022-06-01 美商維它藥物有限責任公司 ＲＯＲ－γ調節劑
JP7106563B2 (ja) 2016-11-29 2022-07-26 スミトモ ファーマ オンコロジー， インコーポレイテッド ナフトフラン誘導体、その調製、および使用方法
CA3062656A1 (en) 2017-05-17 2018-11-22 Boston Biomedical, Inc. Methods for treating cancer
JP2020528904A (ja) 2017-07-24 2020-10-01 ヴァイティー ファーマシューティカルズ，エルエルシー ＲＯＲγの阻害剤
WO2019018975A1 (en) 2017-07-24 2019-01-31 Vitae Pharmaceuticals, Inc. INHIBITORS OF ROR GAMMA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU87821A1 (fr) * 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
US5958954A (en) * 1995-09-01 1999-09-28 Allergan Sales, Inc. Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Also Published As

Publication number Publication date
ES2228587T3 (es) 2005-04-16
EP1206436B1 (en) 2004-10-13
DK1206436T3 (da) 2005-02-14
AU6437300A (en) 2001-02-19
ATE279386T1 (de) 2004-10-15
ZA200200516B (en) 2003-06-25
JP3961827B2 (ja) 2007-08-22
US20050113447A1 (en) 2005-05-26
DE60014928D1 (de) 2004-11-18
WO2001009076A2 (en) 2001-02-08
CA2386793A1 (en) 2001-02-08
EP1206436A2 (en) 2002-05-22
PT1206436E (pt) 2004-12-31
CN1368946A (zh) 2002-09-11
AR024998A1 (es) 2002-11-06
TR200200263T2 (tr) 2004-12-21
JP2003526626A (ja) 2003-09-09
BR0012951A (pt) 2002-04-30
US6528677B1 (en) 2003-03-04
MXPA02000828A (es) 2002-07-30
US20030176726A1 (en) 2003-09-18
KR100466730B1 (ko) 2005-01-24
DE60014928T2 (de) 2006-03-09
US6828337B2 (en) 2004-12-07
CA2386793C (en) 2006-03-28
KR20020030089A (ko) 2002-04-22
AU772551B2 (en) 2004-04-29
WO2001009076A3 (en) 2001-07-19

Similar Documents

Publication Publication Date Title
CN1166618C (zh) 新型选择性视黄醛激动剂
CN1293034C (zh) 新的γ选择性视黄酸类
CN1108289C (zh) 二氟前列腺素衍生物及其使用
CN1215060C (zh) 稠合的吡唑基化合物、包含该化合物的组合物及该化合物的应用
CN1105558C (zh) 2,2－二氯烷羧酸、它们的制备方法、含有它们的药物以及它们在治疗耐胰岛素性中的应用
CN1320599A (zh) 受限的9－顺－视黄酸类
CN1688548A (zh) 喹啉抗生素中间体的制备方法
CN1151144C (zh) Rar选择性视黄酸类激动剂
CN1163604A (zh) 作为基质金属蛋白酶抑制剂的取代的4-二芳基丁酸或5-二芳基戊酸及其衍生物
CN1325380A (zh) 苯衍生物和它们的药物用途
CN1468207A (zh) 用于治疗肺气肿的新的类维生素a类化合物
CN1087622A (zh) 取代的环己烷衍生物、其制备方法和治疗疾病的应用
CN1056680A (zh) 可用作人体白细胞弹性蛋白酶抑制剂的2-苯基链烷酸酯的制备方法
CN1038103A (zh) 环烷基取代的戊二酰胺利尿剂和其制备方法
CN1067892A (zh) 新的吡咯并[2，3-b]吡啶衍生物的制备方法
CN1167670C (zh) 芳基羧酸和四唑衍生物
CN1133621C (zh) 环己二醇衍生物
CN1218467A (zh) 新的含酰胺键的硫衍生物,它们的制备方法,它们作为药物的用途以及含有它们的药物组合物
CN1030074A (zh) 白细胞素拮抗药
CN1098099A (zh) 六氢萘酯衍生物，它们的制备和它们的治疗应用
CN1047857A (zh) α-羟基-3-苯氧基丙胺衍生物及其制造
CN1555357A (zh) 取代的脲的类维生素a激动剂ⅱ
IE920979A1 (en) Pyridazinone acetic acids
SK62293A3 (en) Substituted (benzothiazolyl and quinaxalyl-methoxy) phenyl-acetic acid derivatives
WO2016206373A1 (zh) 一种取代苯乙酸衍生物的制备方法

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20040915